CD8A and esophageal squamous cell carcinoma: Meanwhile, the nomogram model combing CD39-expressing CD8+ T cells with clinical indicators including gender and TNM stage can better predict the prognosis of ESCC patients, and further risk stratification can provide a basis for clinicians to develop individualized treatment plans.